newsfilter
← Latest News
Business Wire·

Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update

Company reports on productive interactions with FDA and preparations for launch of omidubicel, if approved, in advance of May 1 PDUFA date Company outlines strategic restructuring, plans to prioritize omidubicel launch